Sanofi : Dupixent (dupilumab) showed positive topline results in Phase 3 trial of children aged 6 to 11 years with severe atopic dermatitis Read more
GSK grants exclusive technology license for clinical-stage Ebola vaccines to Sabin Vaccine Institute Read more
Bayer and LANXESS to sell their stakes in Currenta to Macquarie Infrastructure and Real Assets Read more
Lilly Announces Positive Results for Emgality (galcanezumab-gnlm) from the CONQUER Study in Patients who Failed Previous Migraine Preventive Treatments Read more
HCL Technologies and Oracle Health Sciences collaborate to accelerate mHealth in clinical trials Read more
Neuropore Therapies and BenevolentAI Enter Strategic Collaboration to Discover Novel Therapeutics Through the Application of Artificial Intelligence Read more
Foamix Submits NDA to FDA for FMX103 for the Treatment of Moderate-to-Severe Papulopustular Rosacea Read more
Sosei Heptares and Takeda enter into new strategic multi-target research, development and commercialization partnership Read more